This inventor holds 1 USPTO granted patent. Top assignee: R.p.scherer Technologies, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Francesca Mary Brewer: Innovator in Pharmaceutical Composition
Introduction
Francesca Mary Brewer is a notable inventor based in Slough, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of compositions aimed at improving drug absorption.
Latest Patents
Francesca holds 1 patent for her invention titled "Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitors." This innovative formulation provides a fast-dispersing oral solid dosage form containing monoamine oxidase B inhibitors, such as selegiline, as the active ingredient. The invention is particularly beneficial for treating diseases like Parkinson's disease. The composition is designed to promote absorption through various mucous membrane tissues, ensuring that at least 5% of the active ingredient is absorbed within one minute of placement in the oral cavity. This method significantly reduces undesirable metabolites associated with the first-pass effect, making it easier for patients who have difficulty swallowing to receive their medication.
Career Highlights
Francesca is associated with R.P. Scherer Technologies, Inc., where she continues to develop innovative pharmaceutical solutions. Her work has been instrumental in advancing the field of drug delivery systems.
Collaborations
Francesca has collaborated with notable colleagues, including Edward Stewart Johnson and Anthony Clarke, contributing to the success of her projects and enhancing the research environment.
Conclusion
Francesca Mary Brewer's contributions to pharmaceutical innovations demonstrate her commitment to improving patient care through effective drug delivery methods. Her work continues to influence the field positively.